The invention provides methods, uses and compositions for the treatment of rheumatoid arthritis. The invention describes methods and uses for treating rheumatoid arthritis wherein a TNFa inhibitor, such as a human TNFa antibody, or antigen-binding portion thereof. Also described are methods for determining the efficacy of a TNFa inhibitor for treatment of rheumatoid arthritis in a subject.